Guided Therapeutics (GTHP) Invested Capital (2016 - 2025)
Historic Invested Capital for Guided Therapeutics (GTHP) over the last 16 years, with Q3 2025 value amounting to -$5.0 million.
- Guided Therapeutics' Invested Capital fell 1716.61% to -$5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.0 million, marking a year-over-year decrease of 1716.61%. This contributed to the annual value of -$4.3 million for FY2024, which is 3144.96% down from last year.
- Latest data reveals that Guided Therapeutics reported Invested Capital of -$5.0 million as of Q3 2025, which was down 1716.61% from -$5.0 million recorded in Q2 2025.
- Guided Therapeutics' Invested Capital's 5-year high stood at $541988.0 during Q1 2024, with a 5-year trough of -$7.9 million in Q1 2021.
- Over the past 5 years, Guided Therapeutics' median Invested Capital value was -$4.3 million (recorded in 2024), while the average stood at -$3.7 million.
- In the last 5 years, Guided Therapeutics' Invested Capital crashed by 5026.69% in 2023 and then surged by 11898.38% in 2024.
- Quarter analysis of 5 years shows Guided Therapeutics' Invested Capital stood at -$5.4 million in 2021, then soared by 57.66% to -$2.3 million in 2022, then plummeted by 41.81% to -$3.3 million in 2023, then tumbled by 31.45% to -$4.3 million in 2024, then decreased by 17.85% to -$5.0 million in 2025.
- Its last three reported values are -$5.0 million in Q3 2025, -$5.0 million for Q2 2025, and $524972.0 during Q1 2025.